Kazia Therapeutics

Follow
Get notifications in MyBN when activity occurs.
Subscribe to BN Log In

Kazia Therapeutics Limited (KZA) is an oncology-focused biotechnology company. KZA is focused on the development of novel anti-cancer drugs based on two proprietary drug technologies known as Super-benzopyrans and Anti-tropomyosins. KZA is headquartered in Sydney, Australia, with an office in New Haven, Connecticut in the US.

Contact Details

Level 24, Three International Towers , 300 Barangaroo Ave SYDNEY NSW 2000
02 9472 4100
www.kaziatherapeutics.com

Lists and Charts

Share price

Kazia Therapeutics
Closing price for the last 90 trading days
View ASX Chart
Powered by Morningstar ®

Revenue

Rank Company #
894th - Kazia Therapeutics $3.39m
1332 public companies - non WA ranked by total revenue
View Full List

Company Share Transactions

20/03/23
$16.20k Bought
Kazia Therapeutics
13/03/23
$16.20k Bought
Kazia Therapeutics
03/03/23
$20.00k Bought
Kazia Therapeutics
Total value as at the date of the transaction
Powered by Morningstar ®

Company Activity

 NEW ROLE: J Friend, 03 Nov 2022
NEW ROLE: K Krumeich, 03 Nov 2022
NEWS: Tagged in Where markets meet medicine; a biotech entrepreneur at the tip of the spear 14 Feb 2022
NEW ROLE: P Leong, 24 Nov 2020
NEW ROLE: G Hirsch, 24 Nov 2020
NEW ROLE: G Heaton, Dir:Finance & Administration 24 Nov 2020
Kate Hill
NEW ROLE: Kate Hill, Company Secretary 24 Nov 2020
NEW ROLE: Steven RS Coffey, Non-Executive Director 03 Nov 2020

News Articles

Related Information

Access to our data for Kazia Therapeutics is only available to paid subscribers with Data & Insights access.

Data & Insights is Western Australia's most accurate and comprehensive business listings and searchable database.

Kazia Therapeutics is included in 1 list - Public Companies - non WA.

For public companies, our subscribers have access to the list of executives and directors along with company financials, director's interests and remuneration.

Subscribe today

X